CHU Toulouse - Hopital Rangueil

Toulouse, Haute-Garonne 31059

1 studies enrolling now · 1 studies all time

What they study most

Intermediate Risk Non-Muscle Invasive Bladder Cancer

Studies at this site

• Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now